| mRNA |
Nutlin-3 |
CCLE |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
PHA-665752 |
CCLE |
pan-cancer |
AAC |
-0.0037 |
0.9 |
| mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.002 |
1 |
| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.0014 |
1 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
| mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
| mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-06 |
| mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-06 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-06 |